Chemical Properties and Facts of 148-51-6

As far as I know, this compound(148-51-6)Application In Synthesis of 5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

The reaction of an aromatic heterocycle with a proton is called a protonation. One of articles about this theory is 《Barriers to Cervical Cancer Screening in Geneva (DEPIST Study).》. Authors are Catarino, Rosa R; Vassilakos, Pierre P; Royannez-Drevard, Isabelle I; Guillot, Cécile C; Alzuphar, Stéphanie S; Fehlmann, Aurore A; Meyer-Hamme, Ulrike U; Petignat, Patrick P.The article about the compound:5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloridecas:148-51-6,SMILESS:OC1=C(C)C(CO)=CN=C1C.[H]Cl).Application In Synthesis of 5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride. Through the article, more information about this compound (cas:148-51-6) is conveyed.

OBJECTIVES: Cervical screening is only efficient if a large part of eligible women participate. Our aim was to identify sociodemographic barriers to cervical screening and consider self-reported reasons to postpone screening. METHODS: Between September 2011 and June 2015, a questionnaire addressing reasons for nonparticipation in cervical screening was completed by 556 women who had not undergone a Pap test in the preceding 3 years. Pearson χ test was used to analyze differences between subgroups. Logistic regression was used to explore the association between sociodemographic characteristics and reasons for nonparticipation. RESULTS: The main reasons for nonparticipation in cervical cancer screening were practical barriers, such as lack of time and the cost of screening. These barriers were more likely to be reported by working women, women who were not sexually active, and those without health insurance. Younger women, non-European women living in Switzerland, and childless women were more likely to have never participated in a screening program before (adjusted odds ratio [aOR], 3.15; 95% CI, 1.41-6.98; aOR, 2.76; 95% CI, 1.48-5.16; aOR, 1.74; 95% CI, 1.03-2.99, respectively). CONCLUSIONS: Practical considerations seem to play a more important role in screening participation than emotional reasons and other beliefs. Particular attention should be paid to immigrant communities, where women seem more likely to skip cervical screening.

As far as I know, this compound(148-51-6)Application In Synthesis of 5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Reference:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

New explortion of 148-51-6

As far as I know, this compound(148-51-6)Product Details of 148-51-6 can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Heterocyclic compounds can be divided into two categories: alicyclic heterocycles and aromatic heterocycles. Compounds whose heterocycles in the molecular skeleton cannot reflect aromaticity are called alicyclic heterocyclic compounds. Compound: 148-51-6, is researched, Molecular C8H12ClNO2, about Quantitative determination of the biological antivitamin B6 effect of pyridoxol antagonists, the main research direction is PYRIDOXOL DEOXY VITAMIN B6; DEOXYPYRIDOXOL VITAMIN B6; ANTIVITAMIN B6 PYRIDOXOLS; VITAMIN B6 PYRIDOXOLS.Product Details of 148-51-6.

Rats were fed a vitamin B6-free diet for 20 days; however, during the last 10 days the diets were supplemented with 30 γ pyridoxol-HCl. During the next 5 days, the animals were loaded with daily oral doses of 200 mg. L-tryptophan/kg., and during days 26-30 of the experiment 4′-deoxypyridoxol-HCl (0.1-100 mg./kg.) was given i.p. 4′-Deoxypyridoxol-HCl had an antivitamin B6 activity (measured by xanthinuric acid excretion) beginning at the 0.3 mg./kg. dose. The antivitamin B6 activity of pyramin-HCl (10-100 mg./kg.) was 60% that of 4′-deoxypyridoxol-HCl.

As far as I know, this compound(148-51-6)Product Details of 148-51-6 can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Reference:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Extended knowledge of 148-51-6

This literature about this compound(148-51-6)Category: pyrimidineshas given us a lot of inspiration, and I hope that the research on this compound(5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride) can be further advanced. Maybe we can get more compounds in a similar way.

Epoxy compounds usually have stronger nucleophilic ability, because the alkyl group on the oxygen atom makes the bond angle smaller, which makes the lone pair of electrons react more dissimilarly with the electron-deficient system. Compound: 5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride, is researched, Molecular C8H12ClNO2, CAS is 148-51-6, about Seizures induced by allylglycine, 3-mercaptopropionic acid, and 4-deoxypyridoxine in mice and photosensitive baboons, and different modes of inhibition of cerebral glutamic acid decarboxylase.Category: pyrimidines.

The title drugs caused seizures in mice (i.p.) and baboons (i.v.) and, at subconvulsant levels, enhanced photo-induced seizures in baboons. Addition of pyridoxal phosphate [54-47-7] to mouse brain homogenate relieved inhibition of L-glutamate 1-carboxylase [9074-87-7] by 4-deoxypyridoxine-HCl [148-51-6] but not by DL-allylglycine [7685-44-1]. 3-Mercaptopropionic acid [107-96-0] was the most powerful competitive inhibitor of the enzyme.

This literature about this compound(148-51-6)Category: pyrimidineshas given us a lot of inspiration, and I hope that the research on this compound(5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride) can be further advanced. Maybe we can get more compounds in a similar way.

Reference:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Little discovery in the laboratory: a new route for 148-51-6

This literature about this compound(148-51-6)Computed Properties of C8H12ClNO2has given us a lot of inspiration, and I hope that the research on this compound(5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride) can be further advanced. Maybe we can get more compounds in a similar way.

The preparation of ester heterocycles mostly uses heteroatoms as nucleophilic sites, which are achieved by intramolecular substitution or addition reactions. Compound: 5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride( cas:148-51-6 ) is researched.Computed Properties of C8H12ClNO2.Sanders, L. B.; Cetorelli, J. J.; Winefordner, James D. published the article 《Phosphorescence characteristics of several antimetabolites》 about this compound( cas:148-51-6 ) in Talanta. Keywords: phosphorescence antimetabolites; antimetabolites phosphorescence. Let’s learn more about this compound (cas:148-51-6).

Phosphorescence excitation and emission wavelength peaks, lifetimes, limits of detection, and concentration ranges of anal. usefulness of 37 antimetabolites in rigid (77°K.) ethanolic solution were determined Seventeen of the metabolites produced anal. useful phosphorescence, whereas the remaining 20 were of limited or no anal. use.

This literature about this compound(148-51-6)Computed Properties of C8H12ClNO2has given us a lot of inspiration, and I hope that the research on this compound(5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride) can be further advanced. Maybe we can get more compounds in a similar way.

Reference:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Top Picks: new discover of 148-51-6

This literature about this compound(148-51-6)Synthetic Route of C8H12ClNO2has given us a lot of inspiration, and I hope that the research on this compound(5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride) can be further advanced. Maybe we can get more compounds in a similar way.

Most of the natural products isolated at present are heterocyclic compounds, so heterocyclic compounds occupy an important position in the research of organic chemistry. A compound: 148-51-6, is researched, SMILESS is OC1=C(C)C(CO)=CN=C1C.[H]Cl, Molecular C8H12ClNO2Journal, Pathologica called Influence of some vitamin B6 antimetabolites on the induction and development of solid IRE reticulosarcoma in rats. I. Deoxypyridoxine, Author is La Pesa, M.; Grimaldi, T.; Curci, E.; Semeraro, N., the main research direction is reticulosarcoma effect deoxypyridoxine; sarcoma effect pyridoxine analog; tumor effect vitamin B6 analog.Synthetic Route of C8H12ClNO2.

Control and exptl. rats were inoculated s.c. in the dorsal region with solid reticulosarcoma IRE. Starting on the 2nd day, each exptl. rat received i.m. 0.35 mg/day of 4-deoxypyridoxine-HCl until death (14-32 days later). The values for latent period, survival, and daily body weight were similar for both groups.

This literature about this compound(148-51-6)Synthetic Route of C8H12ClNO2has given us a lot of inspiration, and I hope that the research on this compound(5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride) can be further advanced. Maybe we can get more compounds in a similar way.

Reference:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Extended knowledge of 148-51-6

This literature about this compound(148-51-6)HPLC of Formula: 148-51-6has given us a lot of inspiration, and I hope that the research on this compound(5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride) can be further advanced. Maybe we can get more compounds in a similar way.

In organic chemistry, atoms other than carbon and hydrogen are generally referred to as heteroatoms. The most common heteroatoms are nitrogen, oxygen and sulfur. Now I present to you an article called Chemistry of vitamin B6. IX. Derivatives of 5-deoxypyridoxine, published in 1953, which mentions a compound: 148-51-6, mainly applied to , HPLC of Formula: 148-51-6.

cf. C.A. 47, 8745g. The 5-deoxy derivatives (I) of pyridoxine (II), pyridoxal (III), and pyridoxamine (IV) were prepared and characterized. The I can participate normally in biochemical reactions involving the substituent at the 4-position but cannot be phosphorylated like II, III, and IV. As expected the I had no vitamin B6 activity but were effective antimetabolites. Codecarboxylase has been catalytically hydrogenated to 5-deoxypyridoxine (V); both II and III yielded under the same conditions a mixture of 4-deoxypyridoxine (VI) and V. The absorption spectra of 5-deoxypyridoxal (VII) (recorded) and pure pyridoxal-5-phosphate (codecarboxylase) (VIII) at pH 11.0 and 1.9, resp., are almost identical. The deep yellow color of both VII and VIII in alk. solution together with other absorption characteristics is ascribed to a quinoid structure. 2-Methyl-3-hydroxy-4-methoxymethyl-5-chloromethylpyridine (IX).HCl (2.38 g.) in 125 cc. MeOH was shaken with H in the presence of 2 g. 5% Pd-Darco, the mixture filtered, and the filtrate concentrated to 20 cc. to yield 1.5 g. (75%) 2,5-dimethyl-3-hydroxy-4-methoxymethylpyridine (X).HCl, m. 152-3° (from EtOH-Et2O). IX.HCl (23.7 g.) reduced similarly in 2 equal portions, each one in 600 cc. MeOH with 5 g. Pd catalyst yielded 19.0 g. (94%) X.HCl. X.HCl (1.47 g.) in 50 cc. 4N HCl heated 3 hrs. at 180-90° in a sealed tube, the colorless solution filtered, the filtrate concentrated to dryness, and the H2O removed azeotropically with EtOH and C6H6 yielded 0.96 g. (70%) V.HCl, m. 143-3.5° (from EtOH-Et2O); treated with excess NaHCO3 gave V, m. 181-2° (from EtOH). X.HCl was treated in H2O with NaHCO3, the mixture concentrated in vacuo and extracted with Et2O, the extract evaporated, 3.1 g. of the residual free base heated 18 hrs. with 50 cc. MeOH and 50 cc. liquid NH3 in a sealed tube, the mixture evaporated in vacuo to dryness, MeOH added and removed twice by distillation, and the residue extracted with Et2O to leave 1.86 g. (60%) 5-deoxypyridoxamine (XI); m. 160-1° (from MeOH); 2,5-dimethyl-3-p-toluenesulfonoxy-4-p-toluenesulfonylaminopyridine-HCl, m. 194-5° (from EtOH). A small sample of XI was heated 20 min. with Ac2O on a steam bath, the solution concentrated to dryness, the residue treated with EtOH, distilled to dryness, dissolved in HCl, treated with Darco, neutralized with NaHCO3, chilled, and the crystalline deposit recrystallized from C6H6 containing a few drops EtOH to give 2,5-dimethyl-3-acetoxy-4-acetylaminomethylpyridine, m. 174-5°. V.HCl (5.7 g.) was stirred 2 hrs. at 60-70° with 2.8 g. MnO2, 1.5 cc. H2SO4, and 75 cc. H2O, the mixture filtered, the filtrate concentrated in vacuo, the sirup taken up in 15 cc. H2O, excess solid AcONa added, and the thick, crystalline precipitate cooled, filtered off, and washed with ice water to give 1.30 g. (29%) VII, m. 108-9° (from petr. ether); the aqueous filtrate from VII gave with 2 g. NH2OH.HCl 0.9 g. (18%) oxime of VII, m. 239-40° (decomposition) (from EtOH). To the aqueous filtrate of a similar run were added 12 g. NaOAc and 4.5 g. NH2OH.HCl and the mixture was heated 10 min. on a steam bath to yield 2.43 g. (49%) oxime of VII. VII in CHCl3 treated with excess alc. HCl, the solution evaporated in vacuo to dryness, a little H2O added and removed in vacuo, and the residue treated with CHCl3 yielded VII.HCl, m. 191-3° (decomposition). VII (90 mg.) in 1 cc. H2O was cooled in ice, the pH adjusted to 11 with 6N NaOH, 4 drops 30% H2O2 added, the mixture adjusted to pH 3 with HCl and cooled, and the precipitate washed with H2O, EtOH, and Et2O to yield 70 mg. (85%) 2,5-dimethyl-3,4-dihydroxypyridine, decomposed 262-70°. Crude Ca codecarboxylase (0.5 g.) was suspended in H2O and treated with 0.7 cc. 6N HCl, the mixture filtered, the filtrate diluted to 50 cc. shaken 2.25 hrs. at atm. pressure with H and 0.5 g. 10% Pd-C, filtered and concentrated to dryness in vacuo, the residue dissolved in about 3 cc. H2O, the solution treated with excess solid NaHCO3, filtered, the filter residue washed with H2O, the combined filtrate and washings were concentrated in vacuo to 5 cc., the concentrate extracted 21 hrs. continuously with CHCl3, the extract evaporated, and the residue treated with alc. HCl and precipitated with Et2O to give 0.07 g. V.HCl, m. 140-1°. III.HCl (0.35 g.) was treated with 0.10 g. CaO and 0.17 g. H3PO4 and hydrogenated similarly to give 0.08 g. (24%) VI.HCl, m. 264-5°, and 0.11 g. (33%) V.HCl; the aqueous filtrate left from the CHCl3-extraction was concentrated to dryness, the residue extracted with EtOH, and the extract acidified with alc. HCl to give 0.11 g. (30%) I.HCl. Similar hydrogenation of 0.40 g. I.HCl in 0.3 cc. 6N HCl and 50 cc. H2O for 4-5 hrs. gave 0.16 g. (42%) VI.HCl and 0.09 g. (24%) V.HCl. Attempted similar hydrogenation of V gave only recovered starting material.

This literature about this compound(148-51-6)HPLC of Formula: 148-51-6has given us a lot of inspiration, and I hope that the research on this compound(5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride) can be further advanced. Maybe we can get more compounds in a similar way.

Reference:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Get Up to Speed Quickly on Emerging Topics: 148-51-6

This literature about this compound(148-51-6)Reference of 5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloridehas given us a lot of inspiration, and I hope that the research on this compound(5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride) can be further advanced. Maybe we can get more compounds in a similar way.

So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic.Horton, R. W.; Meldrum, B. S. researched the compound: 5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride( cas:148-51-6 ).Reference of 5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride.They published the article 《Preconvulsive changes in brain glucose metabolism following drugs inhibiting glutamate decarboxylase》 about this compound( cas:148-51-6 ) in Journal of Neurochemistry. Keywords: convulsant brain glucose glycogen; allylglycine brain glucose glycogen; deoxypyridoxine brain glucose glycogen; methionine sulfoximine brain glucose; isoniazid brain glucose glycogen; temperature brain glucose convulsant. We’ll tell you more about this compound (cas:148-51-6).

DL-C-allylglycine (I) [7685-44-1], 4-deoxypyridoxine-HCl (II) [148-51-6], and DL-methionine-D-sulfoximine (III) (180, 250, and 300 mg/kg resp., i.p.) each induced preconvulsive increases in the brain glucose [50-99-7] concentration of mice at room temperature; II and III also increased brain glycogen [9005-79-2] concentrations in room-temperature mice, but only II did so in mice maintained at 33-4°. Only with I was the increase in brain glucose concentration associated with an increase in blood glucose concentration I, II, III, or isoniazid [54-85-3] (150 mg/kg) reduced rectal temperature in mice at room temperature but not those at 33-4°. Isoniazid reduced brain glucose and glycogen concentrations in mice at 33-4°, but did not affect mice at room temperature The relation between the effects of these drugs on brain carbohydrates and amino acid metabolism is discussed.

This literature about this compound(148-51-6)Reference of 5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloridehas given us a lot of inspiration, and I hope that the research on this compound(5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride) can be further advanced. Maybe we can get more compounds in a similar way.

Reference:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Never Underestimate the Influence Of 148-51-6

This literature about this compound(148-51-6)Name: 5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloridehas given us a lot of inspiration, and I hope that the research on this compound(5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride) can be further advanced. Maybe we can get more compounds in a similar way.

Stone, William E. published the article 《Effects of alterations in the metabolism of γ-aminobutyrate on convulsant potencies》. Keywords: GABA convulsant mechanism; mercaptopropionate convulsion GABA; pentamethylenetetrazole convulsion GABA; bicuculline convulsion GABA; picrotoxin convulsion GABA.They researched the compound: 5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride( cas:148-51-6 ).Name: 5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride. Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:148-51-6) here.

Drugs that alter γ-aminobutyrate (GABA) [56-12-2] metabolism and presumably affect the availability of GABA in synaptic regions were tested for their relative effects on the potencies of 4 convulsants: 3-mercaptopropionate (3-MP) [107-96-0], pentamethylenetetrazole (PTZ) [54-95-5], bicuculline [485-49-4], and picrotoxin [124-87-8] in mice. Aminooxyacetic acid hemichloride [2921-14-4] given prior to the convulsant tended to decrease the potency of 3-MP more than that of PTZ. It decreased the potency of bicuculline more than that of PTZ but less than that of 3-MP, and did not alter that of picrotoxin. Thiocarbohydrazide (TCH) [2231-57-4], DL-C-allylglycine [7685-44-1], and 4-deoxypyridoxine-HCl (DOP) [148-51-6] tended to potentiate 3-MP more than PTZ. The effects of allylglycine on bicuculline and picrotoxin were intermediate. DOP potentiated bicuculline and picrotoxin only to the extent that it potentiated PTZ. TCH resembled DOP in its effect on bicuculline. Valproic acid [99-66-1] decreased the potency of each convulsant; it was most effective against PTZ, slightly less so against 3-MP, and still less effective against bicuculline and picrotoxin. Its anticonvulsive action probably is not primarily via the GABA system. Phenelzine [51-71-8] slightly decreased the potency of bicuculline, but potentiated 3-MP and picrotoxin and did not affect the potency of PTZ. Diacetyl monoxime [57-71-6] was anticonvulsive against PTZ, bicuculline, and picrotoxin, but not against 3-MP. The results do not support the view that bicuculline and picrotoxin induce seizures by blocking GABA-mediated inhibition.

This literature about this compound(148-51-6)Name: 5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloridehas given us a lot of inspiration, and I hope that the research on this compound(5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride) can be further advanced. Maybe we can get more compounds in a similar way.

Reference:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

Simple exploration of 148-51-6

This literature about this compound(148-51-6)Application of 148-51-6has given us a lot of inspiration, and I hope that the research on this compound(5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride) can be further advanced. Maybe we can get more compounds in a similar way.

The reaction of an aromatic heterocycle with a proton is called a protonation. One of articles about this theory is 《The relation between iodine-131 metabolism, tumor growth, and regression》. Authors are Scott, Kenneth G.; Daniels, Marie B..The article about the compound:5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloridecas:148-51-6,SMILESS:OC1=C(C)C(CO)=CN=C1C.[H]Cl).Application of 148-51-6. Through the article, more information about this compound (cas:148-51-6) is conveyed.

Ability of tumors to alter the normal metabolic pathway of I131 and compounds labeled with it (iodide-trapping syndrome) (I) is characterized by higher than normal retention of I131 by skin, muscle, gastrointestinal tract, and plasma, and a lower than normal thyroid uptake and urinary excretion of I131. I was elicited in rats by isografts and homografts of a transmissible fibrosarcoma, but not by homoiografts (which regressed after 5-7 days of growth). The data suggest that local and systemic I parallels progressive tumor growth and is absent in tumor implants destined to regress.

This literature about this compound(148-51-6)Application of 148-51-6has given us a lot of inspiration, and I hope that the research on this compound(5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride) can be further advanced. Maybe we can get more compounds in a similar way.

Reference:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia

The Absolute Best Science Experiment for 148-51-6

This literature about this compound(148-51-6)SDS of cas: 148-51-6has given us a lot of inspiration, and I hope that the research on this compound(5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride) can be further advanced. Maybe we can get more compounds in a similar way.

The reaction of an aromatic heterocycle with a proton is called a protonation. One of articles about this theory is 《Derivatives of pyridine and quinoline. LII. Synthesis of 2,4-dimethyl-3-hydroxy-5-(hydroxymethyl)pyridine (4-desoxyadermine)》. Authors are van Wagtendonk, H. M.; Wibaut, J. P..The article about the compound:5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloridecas:148-51-6,SMILESS:OC1=C(C)C(CO)=CN=C1C.[H]Cl).SDS of cas: 148-51-6. Through the article, more information about this compound (cas:148-51-6) is conveyed.

cf. C. A. 35, 5112.3. NCCH2CONH2 and CH2Ac2 with piperidine in EtOH at 80° give 87% of 4,6-dimethyl-3-cyano-2-pyridone (I), m. 293° (corrected); with HNO3 (d. 1.52) in Ac2O at 5°, I gives a crude yield of 40-6% of the 5-NO2 derivative which with PCl5 in PhCl gives 24-8% of 2,4-dimethyl-3-nitro-5-cyano-6-chloropyridine (II), yellow, m. 114-15°. Catalytic reduction of II with Pd-C in 96% EtOH gives 81.4% of 2,4-dimethyl-3-amino-5-cyano-6-chloropyridine, m. 149-9.2° (corrected); further reduction with Pd-C catalyst in AcOH-AcONa at room temperature gives 2,4-dimethyl-3-amino-5-(aminomethyl)pyridine, characterized as the dipicrate, m. 244° (decomposition), and the di-HCl salt (III), with 1 mol. H2O, does not m. 300°. Reaction of III in 2 N H2SO4 with NaNO2 at 80° gives 2,4-dimethyl-3-hydroxy-5-(hydroxymethyl)pyridine (4-desoxyadermine), isolated as the HCl salt, m. 257°.

This literature about this compound(148-51-6)SDS of cas: 148-51-6has given us a lot of inspiration, and I hope that the research on this compound(5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol hydrochloride) can be further advanced. Maybe we can get more compounds in a similar way.

Reference:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia